Sirona Biochem Corp Stock Number Of Shares Shorted
SRBCF Stock | USD 0.05 0.01 12.50% |
Sirona Biochem Corp fundamentals help investors to digest information that contributes to Sirona Biochem's financial success or failures. It also enables traders to predict the movement of Sirona Pink Sheet. The fundamental analysis module provides a way to measure Sirona Biochem's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sirona Biochem pink sheet.
Sirona |
Sirona Biochem Corp Company Number Of Shares Shorted Analysis
Sirona Biochem's Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
More About Number Of Shares Shorted | All Equity Analysis
Shares Shorted | = | Shorted by Public | + | by Institutions |
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
Competition |
Based on the recorded statements, Sirona Biochem Corp has 0.0 of outstending shares currently sold short by investors. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The number of shares shorted for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run Options Analysis Now
Options AnalysisAnalyze and evaluate options and option chains as a potential hedge for your portfolios |
All Next | Launch Module |
Sirona Fundamentals
Return On Equity | -35.56 | |||
Return On Asset | -1.35 | |||
Operating Margin | (4.92) % | |||
Current Valuation | 24.5 M | |||
Shares Outstanding | 251.73 M | |||
Shares Owned By Insiders | 10.43 % | |||
Price To Earning | (7.33) X | |||
Price To Book | 36.93 X | |||
Price To Sales | 36.46 X | |||
Revenue | 268.02 K | |||
Gross Profit | 199.25 K | |||
EBITDA | (2.3 M) | |||
Net Income | (2.31 M) | |||
Cash And Equivalents | 1.13 M | |||
Total Debt | 468.77 K | |||
Debt To Equity | 0.60 % | |||
Current Ratio | 2.60 X | |||
Book Value Per Share | 0 X | |||
Cash Flow From Operations | (2.16 M) | |||
Earnings Per Share | (0.01) X | |||
Number Of Employees | 12 | |||
Beta | -0.36 | |||
Market Capitalization | 20.74 M | |||
Total Asset | 1.29 M | |||
Retained Earnings | (12.03 M) | |||
Working Capital | 692 K | |||
Current Asset | 1.49 M | |||
Current Liabilities | 801 K | |||
Z Score | 10.5 | |||
Net Asset | 1.29 M |
About Sirona Biochem Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sirona Biochem Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sirona Biochem using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sirona Biochem Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Sirona Pink Sheet
Sirona Biochem financial ratios help investors to determine whether Sirona Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sirona with respect to the benefits of owning Sirona Biochem security.